Literature DB >> 1700019

Multi-pin peptide synthesis strategy for T cell determinant analysis.

N J Maeji1, A M Bray, H M Geysen.   

Abstract

Techniques to synthesize many peptides simultaneously exist, however their individual cleavage and subsequent purification constitutes a bottleneck to total throughput. Biological screening of peptides is generally carried out at physiological pH in aqueous solutions. However, peptides, unless individually purified are usually contaminated by residual compounds used in their preparation such as trifluoroacetic acid, organic solvents, scavengers etc. In testing with cellular systems, such as T cell determinant analysis, such contaminations must be rigorously excluded. We have extended the pin synthesis technique of synthesizing and screening large number of peptides (Geysen et al., 1984) to the analysis of T cell determinants. Peptides can be synthesized on polyethylene pins, the side chain protective groups removed and the peptides washed free of contaminants. A linker system stable under these conditions can then be triggered to cleave the peptides from the pins in an aqueous solution at neutral pH. This strategy enables the rapid mapping of T cell determinants. It is also applicable to other systems where large numbers of solution phase peptides are required, for example, in the study of hormone analogues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700019     DOI: 10.1016/0022-1759(90)90108-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  40 in total

1.  Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease.

Authors:  N Gironès; C I Rodríguez; E Carrasco-Marín; R F Hernáez; J L de Rego; M Fresno
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis.

Authors:  E Peen; C Malone; C Myers; R C Williams; A B Peck; E Csernok; W L Gross; R Staud
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  Use of the multipin peptide synthesis technique for the generation of antipeptide sera.

Authors:  B Triantafyllou; G Tribbick; N J Maeji; H M Geysen
Journal:  Cell Biophys       Date:  1992 Aug-Dec

4.  Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle.

Authors:  H M Vordermeier; A Whelan; P J Cockle; L Farrant; N Palmer; R G Hewinson
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

5.  Conservation of determinants for class II-restricted T cells within site E of influenza virus hemagglutinin and factors influencing their expression.

Authors:  L E Brown; D O White; D C Jackson
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

6.  Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes.

Authors:  E Adams; A Basten; S Rodda; W J Britton
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

7.  Fine mapping of T-cell determinants of bovine beta-lactoglobulin.

Authors:  M Totsuka; A Ametani; S Kaminogawa
Journal:  Cytotechnology       Date:  1997       Impact factor: 2.058

8.  Immunogenicity of peptides for B cells is not impaired by overlapping T-cell epitope topology.

Authors:  D P Harris; H M Vordermeier; A Arya; K Bogdan; C Moreno; J Ivanyi
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

9.  Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.

Authors:  H Saido-Sakanaka; J Ishibashi; A Sagisaka; E Momotani; M Yamakawa
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

10.  Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses.

Authors:  L E Brown; D O White; C Agius; B E Kemp; N Yatzakis; P Poumbourios; D A McPhee; D C Jackson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.